Ameliorating effects of D-47, a newly developed compound, on lipid metabolism in an animal model of familial hypercholesterolemia (WHHLMI rabbits)-Reference-Cited by-同舟云学术

Ameliorating effects of D-47, a newly developed compound, on lipid metabolism in an animal model of familial hypercholesterolemia (WHHLMI rabbits)

Published:2018-03 Issue: Volume:822 Page:147-153
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Tamura Shohei,Koike Yui,Takeda Hiroaki,Koike Tomonari,Izumi Yoshihiro,Nagasaka Ryosuke,Tsunoda Tetsuto,Tori Motoo,Ogawa Kazuo,Bamba Takeshi,Shiomi Masashi

Publisher

Elsevier BV

Subject

Pharmacology

Reference32 articles.

1. Transforming growth factor-β1 inhibits macrophage cholesterol ester accumulation induced by native and oxidized VLDL remnants;Argmann;Arterioscler. Thromb. Vasc. Biol.,2001

2. Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice;Bae;Metabolism,2017

3. A rapid method of total lipid extraction and purification;Bligh;Can. J. Biochem. Phys.,1959

4. A simple method for the isolation and purification of total lipids from animal tissues;Folch;J. Biol. Chem.,1957

5. Lifestyle and dietary interventions in the management of nonalcoholic fatty liver disease;Hannah;Dig. Dis. Sci.,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics investigation of post-mortem human pericardial fluid;International Journal of Legal Medicine;2023-07-04

2. Metabolomics investigation of post-mortem human pericardial fluid;2023-03-01

3. Hepatic Lipid Metabolism Disorder and Atherosclerosis;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-12-20

4. Dietary Sterols and Sterol Oxidation Products on Atherosclerosis: An Insight Provided by Liver Proteomic and Lipidomic;Molecular Nutrition & Food Research;2021-08-31

5. The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (II) - Contribution to the Development and Validation of the Therapeutics for Hypercholesterolemia and Atherosclerosis -;Journal of Atherosclerosis and Thrombosis;2020-02-01